Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WEST PHARMACEUTICAL SERVICES, INC.

(WST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pharmaceutics International, Inc. to Platform West Pharmaceutical Services, Inc.’s Daikyo Crystal Zenith® Container-Closure Components for Aseptic Fill-Finish

08/03/2021 | 08:00am EST

Pharmaceutics International, Inc. (Pii) will include Daikyo Crystal Zenith® (CZ) container-closure components, offered by West Pharmaceutical Services, Inc. (West), as part of its aseptic fill-finish capabilities across vials, syringes and cartridges. Recognizing the growing demand for high-quality and advanced containment systems, as well as small and medium-sized batches, Pii has enabled its AST GeniSYS® R sterile fill-finish system to handle West’s CZ platform to provide customers with more options, greater flexibility, and strategies to de-risk their product development. Pii’s expertise and experience in developing and manufacturing high-value, complex molecules will be greatly improved with the addition of CZ polymer containers that offer high-quality standards, design customizations, and flexibility, along with physical and chemical benefits. Pii’s initial implementation will be filling ready-to-use (RU) syringes and cartridges in its aseptic fill-finish processes. For a typical project, pre-sterilized delivery devices will arrive at facilities in a syringe nesting system using bulk nested trays. This minimizes the risk of contamination and shortens project lead time.


© S&P Capital IQ 2021
All news about WEST PHARMACEUTICAL SERVICES, INC.
11/11West to Participate in Upcoming Investor Conferences
PR
11/09WEST PHARMACEUTICAL SERVICES, INC. : Ex-dividend day for
FA
10/28WEST PHARMACEUTICAL SERVICES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CON..
AQ
10/28Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on..
CI
10/28West Pharmaceutical Services, Inc. Reports Earnings Results for the Third Quarter and N..
CI
10/28West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend - F..
PU
10/28WEST PHARMACEUTICAL SERVICES INC : Results of Operations and Financial Condition, Regulati..
AQ
10/28Q3 2021 West Pharmaceutical Service Earnings Presentation
PU
10/28WEST PHARMACEUTICAL : Q3 Earnings Snapshot
AQ
10/28West Pharmaceutical Services Earnings, Sales Jump in Q3; Lifts FY21 Revenue/EPS Guidanc..
MT
More news
Analyst Recommendations on WEST PHARMACEUTICAL SERVICES, INC.
More recommendations
Financials (USD)
Sales 2021 2 821 M - -
Net income 2021 659 M - -
Net Debt 2021 - - -
P/E ratio 2021 50,2x
Yield 2021 0,16%
Capitalization 31 379 M 31 379 M -
Capi. / Sales 2021 11,1x
Capi. / Sales 2022 10,2x
Nbr of Employees 9 200
Free-Float 97,8%
Chart WEST PHARMACEUTICAL SERVICES, INC.
Duration : Period :
West Pharmaceutical Services, Inc. Technical Analysis Chart | WST | US9553061055 | MarketScreener
Technical analysis trends WEST PHARMACEUTICAL SERVICES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 434,13 $
Average target price 425,00 $
Spread / Average Target -2,10%
EPS Revisions
Managers and Directors
Eric Mark Green President, Chief Executive Officer & Director
Bernard J. Birkett Chief Financial Officer, Treasurer & Senior VP
Patrick J. Zenner Non-Executive Chairman
Silji Abraham Chief Technology Officer & Senior Vice President
David A. Montecalvo SVP, Chief Operations & Supply Chain Officer
Sector and Competitors
1st jan.Capi. (M$)
WEST PHARMACEUTICAL SERVICES, INC.49.51%32 160
ABBOTT LABORATORIES18.98%230 355
MEDTRONIC PLC-8.77%143 693
BECTON, DICKINSON AND COMPANY-3.42%69 336
HOYA CORPORATION25.75%59 756
DEXCOM, INC.40.51%50 350